Skip to main content
. 2022 May 18;24(Suppl C):C254–C271. doi: 10.1093/eurheartj/suac020

Figure 4.

Figure 4

Decision-making algorithm on antithrombotic therapy to be applied at the time of discharge of AF patients undergoing PCI. N.B. It is possible to replace clopidogrel or ticagrelor with aspirin in case of intolerance, contraindications or side effects. ACS, acute coronary syndrome; CCS, chronic coronary syndrome; DAT, double antithrombotic therapy (1 antiplatelet + 1 anticoagulant); PCI, coronary angioplasty; TAT, triple antithrombotic therapy (2 antiplatelet + 1 anticoagulant). aFinal TIMI flow 0/1, residual dissection, residual intracoronary thrombosis, or subtraction angiography images, inadequate stent expansion or rupture; see Table 5 criteria, excluding long-term OA from the assessment of the major criteria. To be considered at high bleeding risk, patients must have at least one higher risk criterion or at least two minors; bSee criteria in Table 3; cReduce the dosage according to the instructions in the package leaflet.